abrdn Healthcare Investors (NYSE:HQH – Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totaling 50,688 shares, an increase of 44.6% from the December 15th total of 35,063 shares. Approximately 0.1% of the company’s shares are short sold. Based on an average daily volume of 150,900 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 150,900 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the company’s shares are short sold.
abrdn Healthcare Investors Stock Performance
abrdn Healthcare Investors stock traded down $0.16 during mid-day trading on Friday, hitting $18.85. 540,398 shares of the company’s stock were exchanged, compared to its average volume of 160,406. The company’s 50 day simple moving average is $18.98 and its 200-day simple moving average is $17.73. abrdn Healthcare Investors has a fifty-two week low of $13.77 and a fifty-two week high of $19.69.
abrdn Healthcare Investors Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 12th. Stockholders of record on Friday, November 21st were issued a dividend of $0.57 per share. This is a boost from abrdn Healthcare Investors’s previous quarterly dividend of $0.51. The ex-dividend date was Friday, November 21st. This represents a $2.28 annualized dividend and a dividend yield of 12.1%.
Institutional Investors Weigh In On abrdn Healthcare Investors
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Further Reading
- Five stocks we like better than abrdn Healthcare Investors
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
